Original Research
Published on 30 May 2024
Cost-effectiveness analysis of bevacizumab combined with lomustine in the treatment of progressive glioblastoma using a Markov model simulation analysis
in Health Economics
![Cost-effectiveness analysis of bevacizumab combined with lomustine in the treatment of progressive glioblastoma using a Markov model simulation analysis](https://www.frontiersin.org/files/myhome article library/1410355/1410355_Thumb_400.jpg)
- 804 views
Original Research
Published on 30 May 2024
in Health Economics
Perspective
Published on 30 May 2024
in Health Economics
Original Research
Published on 30 May 2024
in Health Economics
Original Research
Published on 28 May 2024
in Health Economics
Original Research
Published on 28 May 2024
in Health Economics
Original Research
Published on 23 May 2024
in Health Economics
Original Research
Published on 22 May 2024
in Health Economics
Editorial
Published on 20 May 2024
in Health Economics
Original Research
Published on 20 May 2024
in Health Economics
Original Research
Published on 20 May 2024
in Health Economics
Original Research
Published on 17 May 2024
in Health Economics
Original Research
Published on 16 May 2024
in Health Economics
Original Research
Published on 16 May 2024
in Health Economics
Original Research
Published on 16 May 2024
in Health Economics
Original Research
Published on 15 May 2024
in Health Economics
Original Research
Published on 13 May 2024
in Health Economics